These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 33323902)
1. ANGIOGRAPHIC RISK FACTORS FOR RECURRENCE OF MACULAR EDEMA ASSOCIATED WITH BRANCH RETINAL VEIN OCCLUSION. Kogo T; Muraoka Y; Uji A; Ooto S; Murakami T; Kadomoto S; Iida-Miwa Y; Miyake M; Miyata M; Tsujikawa A Retina; 2021 Jun; 41(6):1219-1226. PubMed ID: 33323902 [TBL] [Abstract][Full Text] [Related]
2. EVALUATION OF MACULAR ISCHEMIA IN EYES WITH BRANCH RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study. Kadomoto S; Muraoka Y; Ooto S; Miwa Y; Iida Y; Suzuma K; Murakami T; Ghashut R; Tsujikawa A; Yoshimura N Retina; 2018 Feb; 38(2):272-282. PubMed ID: 28221256 [TBL] [Abstract][Full Text] [Related]
3. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion. Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569 [TBL] [Abstract][Full Text] [Related]
4. NOVEL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY BIOMARKER IN BRANCH RETINAL VEIN OCCLUSION MACULAR EDEMA. Yeung L; Wu WC; Chuang LH; Wang NK; Lai CC Retina; 2019 Oct; 39(10):1906-1916. PubMed ID: 30028408 [TBL] [Abstract][Full Text] [Related]
5. COMBINATION THERAPY OF INTRAVITREAL RANIBIZUMAB AND SUBTHRESHOLD MICROPULSE PHOTOCOAGULATION FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION: 6-MONTH RESULT. Terashima H; Hasebe H; Okamoto F; Matsuoka N; Sato Y; Fukuchi T Retina; 2019 Jul; 39(7):1377-1384. PubMed ID: 29689025 [TBL] [Abstract][Full Text] [Related]
6. BETTER PROGNOSIS FOR EYES WITH PRESERVED FOVEAL DEPRESSION AFTER INTRAVITREAL RANIBIZUMAB INJECTION FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION. Kitagawa S; Yasuda S; Ito Y; Ueno S; Iwase T; Terasaki H Retina; 2018 Jul; 38(7):1354-1360. PubMed ID: 28538263 [TBL] [Abstract][Full Text] [Related]
7. Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion. Hasegawa T; Takahashi Y; Maruko I; Kogure A; Iida T Br J Ophthalmol; 2019 Oct; 103(10):1367-1372. PubMed ID: 30514711 [TBL] [Abstract][Full Text] [Related]
8. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT. Tang F; Qin X; Lu J; Song P; Li M; Ma X Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion. Son BK; Kwak HW; Kim ES; Yu SY Korean J Ophthalmol; 2017 Jun; 31(3):209-216. PubMed ID: 28471106 [TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography angiography findings in patients with branch retinal vein occlusion treated with Anti-VEGF. Ciloglu E; Dogan NÇ Arq Bras Oftalmol; 2020; 83(2):120-126. PubMed ID: 31778447 [TBL] [Abstract][Full Text] [Related]
11. MACULAR BLOOD FLOW CHANGES IN BRANCH RETINAL VEIN OCCLUSION EXAMINED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VARIABLE INTERSCAN TIME ANALYSIS. Nishigori N; Muraoka Y; Ishikura M; Kadomoto S; Mori Y; Numa S; Murakami T; Ooto S; Tsujikawa A Retina; 2022 Nov; 42(11):2210-2217. PubMed ID: 35982475 [TBL] [Abstract][Full Text] [Related]
12. FIXATION STATUS AFTER RESOLUTION OF MACULAR EDEMA ASSOCIATED WITH BRANCH RETINAL VEIN OCCLUSION. Kogo T; Muraoka Y; Ooto S; Suzuma K; Murakami T; Iida Y; Iida-Miwa Y; Ghashut R; Miyata M; Tsujikawa A Retina; 2019 Oct; 39(10):1896-1905. PubMed ID: 30015761 [TBL] [Abstract][Full Text] [Related]
13. Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema. Goel S; Kumar A; Ravani RD; Chandra P; Chandra M; Kumar V Indian J Ophthalmol; 2019 Jul; 67(7):1105-1108. PubMed ID: 31238421 [TBL] [Abstract][Full Text] [Related]
14. Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion. Pichi F; Elbarky AM; Elhamaky TR Int Ophthalmol; 2019 Jan; 39(1):145-153. PubMed ID: 29274022 [TBL] [Abstract][Full Text] [Related]
15. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION. Lotfy A; Solaiman KAM; Abdelrahman A; Samir A Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552 [TBL] [Abstract][Full Text] [Related]
16. Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial. Song S; Yu X; Zhang P; Gu X; Dai H BMC Ophthalmol; 2020 Jun; 20(1):241. PubMed ID: 32560639 [TBL] [Abstract][Full Text] [Related]
17. Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study. Callizo J; Atili A; Striebe NA; Bemme S; Feltgen N; Hoerauf H; Bertelmann T Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):913-920. PubMed ID: 30610424 [TBL] [Abstract][Full Text] [Related]
18. CLINICAL FINDINGS OF EYES WITH MACULAR EDEMA ASSOCIATED WITH BRANCH RETINAL VEIN OCCLUSION REFRACTORY TO RANIBIZUMAB. Hasegawa T; Kawano T; Maruko I; Koizumi H; Iida T Retina; 2018 Jul; 38(7):1347-1353. PubMed ID: 28492435 [TBL] [Abstract][Full Text] [Related]
19. Patterns of Macular Edema in Branch Retinal Vein Occlusion Diagnosed by Optical Coherence Tomography. Gupta S; Thapa R; Pradhan E; Bajimaya S; Sharma S; Duwal S Nepal J Ophthalmol; 2023 Jul; 15(30):55-62. PubMed ID: 38976337 [TBL] [Abstract][Full Text] [Related]
20. Gap in Capillary Perfusion on Optical Coherence Tomography Angiography Associated With Persistent Macular Edema in Branch Retinal Vein Occlusion. Tsuboi K; Ishida Y; Kamei M Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2038-2043. PubMed ID: 28384724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]